Marjorie Baciuchka

Sign up to set email alerts
|
27Publications
864Citation Statements Received
93Citation Statements Given
How they've been cited
1,299
23
836
5
How they cite others
543
3
88
2
Publications
Order By: Most citations

Androgen-deprivation therapy alone or with docetaxel in non-castrate metastatic prostate cancer (GETUG-AFU 15): a randomised, open-label, phase 3 trial

Gravis
1
,
Fizazi
2
,
Joly
3
et al. 2013
The Lancet Oncology
614
10
438
3
View full textAdd to dashboardCite

Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial

Fizazi
1
,
Faivre
2
,
Lesaunier
3
et al. 2015
The Lancet Oncology
208
3
117
0
View full textAdd to dashboardCite

Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model

Gravis
1
,
Boher
2
,
Fizazi
3
et al. 2015
European Urology
111
7
85
2
View full textAdd to dashboardCite

Patients’ self-assessment versus investigators’ evaluation in a phase III trial in non-castrate metastatic prostate cancer (GETUG-AFU 15)

Gravis
1
,
Marino
2
,
Joly
3
et al. 2014
European Journal of Cancer
62
2
37
0
View full textAdd to dashboardCite

A phase III trial of docetaxel–estramustine in high-risk localised prostate cancer: A planned analysis of response, toxicity and quality of life in the GETUG 12 trial

Fizazi
1
,
Lesaunier
2
,
Delva3
et al. 2012
European Journal of Cancer
47
0
30
0
View full textAdd to dashboardCite

Anticancer Activity and Tolerance of Treatments Received Beyond Progression in Men Treated Upfront with Androgen Deprivation Therapy With or Without Docetaxel for Metastatic Castration-naïve Prostate Cancer in the GETUG-AFU 15 Phase 3 Trial

Lavaud
1
,
Gravis
2
,
Foulon
3
et al. 2018
European Urology
46
0
24
0
View full textAdd to dashboardCite

Outcome According to Elective Pelvic Radiation Therapy in Patients With High-Risk Localized Prostate Cancer: A Secondary Analysis of the GETUG 12 Phase 3 Randomized Trial

Blanchard
1
,
Faivre
2
,
Lesaunier
3
et al. 2016
International Journal of Radiation Oncology*Biology*Physics
27
0
20
0
1
View full textAdd to dashboardCite

Body image and psychological distress in women with breast cancer: a French online survey on patients’ perceptions and expectations

Pierrisnard
1
,
Baciuchka
2
,
Mancini
3
et al. 2017
Breast Cancer
71
0
21
0
View full textAdd to dashboardCite
show abstract
scite logo

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

334 Leonard St

Brooklyn, NY 11211

Product
Browser ExtensionAssistant by sciteCitation Statement SearchReference CheckVisualizationsDashboardsExplore JournalsExplore OrganizationsExplore FundersEmbedding BadgeEmbedding Citation SearchPricing
Resources
BlogHelp & FAQAccessibility StatementAPI TermsFor Universities & GovernmentsFor ResearchersFor PublishersFor Corporate, Pharma & EnterpriseAuthor MarketingBecome an AffiliateGet an organization trial or quotescite Data & Services
About
News & PressCareersRead our PaperCoverage

BlogTerms and ConditionsAPI TermsPrivacy PolicyContactCookie PreferencesDo Not Sell or Share My Personal Information

Copyright © 2024 scite LLC. All rights reserved.

Made with 💙 for researchers

Part of the Research Solutions Family.